NanoViricides Inc. (NNVC)

[freethemice]

From the PR on Feb 4th.
Tuesday, February 4th, 2014 - NanoViricides, Inc. (NYSE MKT: NNVC) (the “Company”) reported today that it
has signed a “confidential disclosure agreement” (“CDA”) with Viroclinics Biosciences, BV (“Viroclinics”), a
spinoff of the Department of Viroscience at the Erasmus Medical Centre (“Erasmus”) in Rotterdam, the
Netherlands.

New Journal of Virology paper published ahead of print on Jan 29, 2014. Shows off their testing abilities.

Novel Avian-Origin Influenza A (H7N9) Virus Attachment to the Respiratory Tract of Five Animal Models
Jurre Y. Siegers a, Kirsty R. Short a, Lonneke M.E. Leijten a, Miranda de Graaf a, Monique I.J. Spronken a, Eefje J.A. Schrauwen a, Nicolle Marshall b, Anice C. Lowen b, Gülsah Gabriel c, Albert D.M.E Osterhaus a, Thijs Kuiken a and Debby van Riel a#
- Author Affiliations

a Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
b Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA
c Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany

ABSTRACT
We determined the attachment pattern of avian-origin H7N9 influenza viruses A/Anhui/1/2013 and A/Shanghai/1/2013 to the respiratory tract in ferrets, macaques, mice, pigs and guinea pigs, and compared it to that in humans. The H7N9 attachment pattern in macaques, mice, and to a lesser extent pigs and guinea pigs resembled that in humans more closely than the attachment pattern in ferrets. This knowledge contributes to our knowledge on the different animal models for influenza.